Edition:
United States

NuVasive Inc (NUVA.OQ)

NUVA.OQ on NASDAQ Stock Exchange Global Select Market

61.54USD
22 Jul 2016
Change (% chg)

$-0.37 (-0.60%)
Prev Close
$61.91
Open
$61.78
Day's High
$61.99
Day's Low
$61.01
Volume
94,792
Avg. Vol
210,274
52-wk High
$62.91
52-wk Low
$36.81

NUVA.OQ

Chart for NUVA.OQ

About

Nuvasive, Inc. is a medical device company in the spine market. The Company focuses on developing minimally-disruptive surgical products and procedurally-integrated solutions for the spine. The Company offers two product lines: spine surgery products and biologics. The Company's spine surgery products line offerings include... (more)

Overall

Beta: 0.97
Market Cap(Mil.): $3,066.73
Shares Outstanding(Mil.): 49.83
Dividend: --
Yield (%): --

Financials

  NUVA.OQ Industry Sector
P/E (TTM): 128.24 43.63 37.05
EPS (TTM): 0.48 -- --
ROI: 1.88 11.61 14.35
ROE: 3.98 13.64 15.56

NuVasive settles spinal surgery patent fight with Medtronic

Medical device maker NuVasive Inc will pay rival Medtronic Plc $45 million to settle a longstanding patent fight related to spinal surgery technology, NuVasive said on Thursday.

Jun 30 2016

NuVasive settles spinal surgery patent fight with Medtronic

Medical device maker NuVasive Inc will pay rival Medtronic Plc $45 million to settle a longstanding patent fight related to spinal surgery technology, NuVasive said on Thursday.

Jun 30 2016

UPDATE 1-NuVasive settles spinal surgery patent fight with Medtronic

June 30 Medical device maker NuVasive Inc will pay rival Medtronic Plc $45 million to settle a longstanding patent fight related to spinal surgery technology, NuVasive said on Thursday.

Jun 30 2016

BRIEF-Nuvasive agrees to settle patent litigation with Medtronic

* Nuvasive and Medtronic reached agreement on terms for settlement of previously disclosed patent infringement lawsuits

Jun 30 2016

BRIEF-NuVasive to acquire Biotronic NeuroNetwork

* Board of directors of both companies have unanimously approved transaction

Jun 06 2016

On second round, Federal Circuit still finds Medtronic infringes NuVasive patent

Medical device manufacturer Medtronic PLC cannot escape a jury finding that it infringed rival NuVasive Inc's surgical nerve monitoring technology, a federal appeals court ruled on Friday.

Jun 06 2016

BRIEF-Nuvasive Q1 non-GAAP earnings per share $0.31

* Sees 2016 revenue of approximately $928.0 million, or approximately 14.4% growth compared to revenue of $811.1 million for 2015

Apr 26 2016

Earnings vs. Estimates